209 related articles for article (PubMed ID: 22460341)
21. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study.
Prinster A; Quarantelli M; Orefice G; Lanzillo R; Brunetti A; Mollica C; Salvatore E; Morra VB; Coppola G; Vacca G; Alfano B; Salvatore M
Neuroimage; 2006 Feb; 29(3):859-67. PubMed ID: 16203159
[TBL] [Abstract][Full Text] [Related]
22. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
[TBL] [Abstract][Full Text] [Related]
23. In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM.
Shigemoto Y; Matsuda H; Kamiya K; Maikusa N; Nakata Y; Ito K; Ota M; Matsunaga N; Sato N
Neuroimage Clin; 2013; 2():491-6. PubMed ID: 24179801
[TBL] [Abstract][Full Text] [Related]
24. Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis.
Pagani E; Storelli L; Pantano P; Petsas N; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
J Neurol; 2023 Jan; 270(1):446-459. PubMed ID: 36152049
[TBL] [Abstract][Full Text] [Related]
25. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
26. Two-year regional grey and white matter volume changes with natalizumab and fingolimod.
Preziosa P; Rocca MA; Pagani E; Storelli L; Rodegher M; Moiola L; Filippi M
J Neurol Neurosurg Psychiatry; 2020 May; 91(5):493-502. PubMed ID: 32111638
[TBL] [Abstract][Full Text] [Related]
27. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
28. Localization of grey matter atrophy in early RRMS : A longitudinal study.
Audoin B; Davies GR; Finisku L; Chard DT; Thompson AJ; Miller DH
J Neurol; 2006 Nov; 253(11):1495-501. PubMed ID: 17093899
[TBL] [Abstract][Full Text] [Related]
29. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
[TBL] [Abstract][Full Text] [Related]
30. Gray matter atrophy is related to long-term disability in multiple sclerosis.
Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
[TBL] [Abstract][Full Text] [Related]
31. Exploration of the relationships between regional grey matter atrophy and cognition in multiple sclerosis.
Nocentini U; Bozzali M; Spanò B; Cercignani M; Serra L; Basile B; Mannu R; Caltagirone C; De Luca J
Brain Imaging Behav; 2014 Sep; 8(3):378-86. PubMed ID: 22584774
[TBL] [Abstract][Full Text] [Related]
32. Hypoperfusion of the thalamus is associated with disability in relapsing remitting multiple sclerosis.
Doche E; Lecocq A; Maarouf A; Duhamel G; Soulier E; Confort-Gouny S; Rico A; Guye M; Audoin B; Pelletier J; Ranjeva JP; Zaaraoui W
J Neuroradiol; 2017 Mar; 44(2):158-164. PubMed ID: 27865557
[TBL] [Abstract][Full Text] [Related]
33. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.
Sepulcre J; Goñi J; Masdeu JC; Bejarano B; Vélez de Mendizábal N; Toledo JB; Villoslada P
Arch Neurol; 2009 Feb; 66(2):173-9. PubMed ID: 19204153
[TBL] [Abstract][Full Text] [Related]
34. Quantification of global cerebral atrophy in multiple sclerosis from 3T MRI using SPM: the role of misclassification errors.
Dell'Oglio E; Ceccarelli A; Glanz BI; Healy BC; Tauhid S; Arora A; Saravanan N; Bruha MJ; Vartanian AV; Dupuy SL; Benedict RHB; Bakshi R; Neema M
J Neuroimaging; 2015; 25(2):191-199. PubMed ID: 25523616
[TBL] [Abstract][Full Text] [Related]
35. New rapid, accurate T
Shepherd TM; Kirov II; Charlson E; Bruno M; Babb J; Sodickson DK; Ben-Eliezer N
Neuroimage Clin; 2017; 14():363-370. PubMed ID: 28239545
[TBL] [Abstract][Full Text] [Related]
36. Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.
Donadieu M; Le Fur Y; Lecocq A; Maudsley AA; Gherib S; Soulier E; Confort-Gouny S; Pariollaud F; Ranjeva MP; Pelletier J; Guye M; Zaaraoui W; Audoin B; Ranjeva JP
J Magn Reson Imaging; 2016 Aug; 44(2):411-9. PubMed ID: 26756662
[TBL] [Abstract][Full Text] [Related]
37. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
38. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes.
Ceccarelli A; Rocca MA; Pagani E; Colombo B; Martinelli V; Comi G; Filippi M
Neuroimage; 2008 Aug; 42(1):315-22. PubMed ID: 18501636
[TBL] [Abstract][Full Text] [Related]
39. The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI study.
Ceccarelli A; Rocca MA; Pagani E; Ghezzi A; Capra R; Falini A; Scotti G; Comi G; Filippi M
Neuroimage; 2008 Feb; 39(4):1499-509. PubMed ID: 18155611
[TBL] [Abstract][Full Text] [Related]
40. Brain macro- and microscopic damage in patients with paediatric MS.
Absinta M; Rocca MA; Moiola L; Ghezzi A; Milani N; Veggiotti P; Comi G; Filippi M
J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1357-62. PubMed ID: 20660915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
